Form D · Biotechnology
MESOBLAST LTD
Melbourne, Victoria, C3 · CIK 0001345099
Offering snapshot reported May 26, 2020 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 12, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2020 | Initial | $6,498,939 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $260K
- Finders' fees
- $0
- Form D file number
- 021-367633
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bell Potter Securities (US) LLC | 289328 |
Source: Form D, filed May 26, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Burns | Director |
| Charlie Harrison | Executive |
| Peter Howard | Executive |
| Silviu Itescu | Director, Executive |
| Josh Muntner | Executive |
| Donal O'dwyer | Director |
| Eric Rose | Director |
| Niva Sivakumar | Executive |
| Michael Spooner | Director |
| Joseph Swedish | Director |
| Shawn Cline Tomasello | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Level 38 55 Collins Street
Melbourne, Victoria, C3, 3000
Melbourne, Victoria, C3, 3000